JP Patent

JP6426085B2 — 損傷のない神経組織伝導ブロック用の治療送達装置および方法

Assigned to Case Western Reserve University · Expires 2018-11-21 · 7y expired

What this patent protects

Patent listed against treprostinil-sodium.

Drugs covered by this patent

treprostinil-sodium (TREPROSTINIL SODIUM)

Patent Metadata

Patent number: JP6426085B2
Jurisdiction: JP
Classification: —
Expires: 2018-11-21
Drug substance claim: No
Drug product claim: No
Assignee: Case Western Reserve University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.